Stockscreener 앱 받기
14.67
8.11%
1.10
전일 마감가:
$13.57
열려 있는:
$13.42
하루 거래량:
1.30M
Relative Volume:
0.72
시가총액:
$1.61B
수익:
$-249.00K
순이익/손실:
$-187.60M
주가수익비율:
-5.868
EPS:
-2.5
순현금흐름:
$-201.88M
1주 성능:
+15.60%
1개월 성능:
-4.05%
6개월 성능:
+170.17%
1년 성능:
+182.66%
1일 변동 폭
$13.08
$14.84
1주일 범위
$12.61
$15.09
52주 변동 폭
$2.865
$16.96
Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile
명칭
Amylyx Pharmaceuticals Inc
전화
617-683-0917
주소
43 THORNDIKE STREET, CAMBRIDGE
AMLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMLX
Amylyx Pharmaceuticals Inc
|
14.67 | 1.49B | -249.00K | -187.60M | -201.88M | -2.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Buy |
| 2025-06-24 | 개시 | Guggenheim | Buy |
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2025-05-30 | 개시 | TD Cowen | Buy |
| 2025-04-07 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-11-18 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-10-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-03-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2024-03-11 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-11 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-03-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-03-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-01-03 | 개시 | Robert W. Baird | Outperform |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-07-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-03-31 | 개시 | Mizuho | Buy |
| 2023-01-05 | 개시 | BofA Securities | Buy |
| 2022-05-25 | 개시 | Citigroup | Buy |
| 2022-04-01 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
Amylyx Pharmaceuticals Inc 주식(AMLX)의 최신 뉴스
How sustainable is Amylyx Pharmaceuticals Inc. stock dividend payoutWeekly Trade Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Is Amylyx Pharmaceuticals Inc. stock positioned for digital transformationWeekly Stock Recap & Consistent Growth Stock Picks - newser.com
Can Amylyx Pharmaceuticals Inc. stock reach $100 price targetJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Is Amylyx Pharmaceuticals Inc. stock attractive for growth ETFsOil Prices & Weekly Watchlist for Consistent Profits - newser.com
What the charts say about Amylyx Pharmaceuticals Inc. today2025 Year in Review & Stepwise Trade Signal Guides - newser.com
Will Amylyx Pharmaceuticals Inc. stock deliver better than expected guidanceGap Up & Weekly Return Optimization Plans - newser.com
Real time social sentiment graph for Amylyx Pharmaceuticals Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com
Is Amylyx Pharmaceuticals Inc. stock attractive for long term wealth buildingTrade Volume Report & Capital Protection Trade Alerts - newser.com
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead - AOL.com
Real time alert setup for Amylyx Pharmaceuticals Inc. performanceWeekly Gains Summary & Growth Focused Stock Reports - newser.com
Is Amylyx Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
Trend analysis for Amylyx Pharmaceuticals Inc. this weekTrade Entry Report & Safe Capital Growth Plans - newser.com
What’s the recovery path for long term holders of Amylyx Pharmaceuticals Inc.Layoff News & Smart Allocation Stock Reports - newser.com
Measuring Amylyx Pharmaceuticals Inc.’s beta against major indicesIndex Update & Reliable Intraday Trade Plans - newser.com
Applying Wyckoff theory to Amylyx Pharmaceuticals Inc. stockWeekly Profit Recap & Verified Momentum Watchlists - newser.com
Published on: 2025-11-13 23:21:08 - newser.com
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX - The Joplin Globe
Using portfolio simulators with Amylyx Pharmaceuticals Inc. included2025 Key Lessons & Safe Investment Capital Preservation Plans - newser.com
Amylyx Pharmaceuticals Inc (AMLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):